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Abstract
Background-: Left ventricular outflow tract obstruction is an independent predictor of adverse
outcome in hypertrophic cardiomyopathy (HCM). The classical quantification of intraventricular
obstruction is performed in resting conditions in supine position, but this assessment does not
reflect what happens in HCM patients (pts) in their daily activities, neither during effort nor during
orthostatic recovery.
Aim-: To assess intraventricular gradients with echocardiography during treadmill exercise and in
the recovery period in upright position, in HCM pts.
Methods-: We studied 17 HCM pts (9 males, mean age 53 ± 16 years, 11 with obstructive HCM).
Each pt had 2 echocardiographic evaluations at rest (left lateral decubitus (LLD) and orthostatic
position). The pts then underwent a treadmill exercise test and intraventricular gradients were
measured at peak exercise and during recovery in orthostatic position.
Results-: 3 pts with non-obstructive HCM at rest developed intraventricular gradients during
exercise. 1 pt developed this gradient only during orthostatic recovery. The mean intraventricular
gradient in LLD was 49 ± 24 mmHg; in orthostatic position was 62 ± 29 mmHg (p < 0.001 versus
in LLD); at peak exercise was 83 ± 35 mmHg (p < 0.001 versus supine rest); during recovery it was
96 ± 35 mmHg (p < 0.001 versus peak exercise)
Conclusion-: In HCM pts the intraventricular gradient increases in orthostatic position, increases
significantly during treadmill exercise and continues increasing in the recovery period in orthostatic
position. This type of evaluation can help us to better understand the physiopathology, the
symptoms and the efficacy of different therapeutic modalities in this disease and should be routinely
used in the assessment of HCM pts.
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Introduction
Hypertrophic cardiomyopathy (HCM) is an inherited
heart muscle disorder, generally characterised by asym-
metric hypertrophy of left ventricular walls in the absence
of another cardiac or systemic disease capable of produc-
ing a similar hypertrophy. It is a complex entity caused by
a wide range of genetic, morphological and functional
alterations [1-5]. A prevalence of 0.2% has been reported
in the general population [6].
Approximately 25% of patients with HCM have a
dynamic systolic pressure gradient in the left ventricular
outflow tract caused by contact between the mitral valve
leaflet(s) and the interventricular septum under resting
conditions [7-11].
Outflow tract gradient in excess of 30 mmHg is an impor-
tant cause of symptoms. Some authors believe that the
gradient is simply a consequence of high velocity flow
through the aortic valve, and hence does not represent a
real obstruction to cardiac output. However, if the gradi-
ent is greater than 50 mmHg, the percentage of systolic
volume ejected before the beginning of SAM is greatly
reduced and this is probably responsible for patients'
symptoms [12]; when severe, outflow tract gradient can
cause dyspnoea, chest pain, syncope, and predisposes to
the development of atrial arrhythmias [7]; it is also an
independent predictor of disease progression and adverse
outcome, including sudden death [13-16].
Evaluation of pts with HCM usually consists of serial
echocardiographic studies in resting conditions and thus
the results obtained may not reflect the heart's behavior
during a patient's daily activities or the pathophysiology
of this condition. The intraventricular gradient in HCM is
dynamic, being greater in situations of increased LV con-
tractility and reduced preload and afterload [17,18].
A recent study by Shah et al [19] demonstrates that up to
two-thirds of symptomatic patients with non-obstructive
HCM develop obstruction during upright exercise on a
bicycle, confirming the findings in a study by Maron et al
[20]. In this study by Shah et al [19], patients with exercise
induced obstruction tend to have higher peak oxygen con-
sumption than non-obstructive patients, and the gradient
changes during exercise correlate with a history of syn-
cope/presyncope. These findings have implications for
the evaluation of patients with HCM, raising questions
about the relation between LVOT obstruction and cardiac
function, suggesting that all patients with symptomatic
non-obstructive HCM at rest should have exercise stress
[19].
In our department, exercise echocardiography with image
acquisition during treadmill exercise (considered to
reflect exercise during daily activities) is commonly used
in the evaluation of pts with HCM, enabling assessment of
outflow gradient during physiologic exercise and in recov-
ery period in left lateral decubitus (LLD) [21]. In patients
with obstructive HCM under resting conditions, it has
been demonstrated that obstruction may increase after
change of position from supine to upright [22]. In this
study by Cotrim et al, LVOT gradient increased in orthos-
tatic position, continued to augment at peak exercise, but
after exercise the gradient decreased rapidly when meas-
ured in LLD, concluding that assessment of intraventricu-
lar gradient in recovery period in supine position does not
reflect changes during effort [22]. LVOT gradient meas-
ured in recovery period in supine position does not reflect
patients daily activities (pts simply don't assume supine
position after an effort in their daily life) nor the patho-
physiology of this condition [17,18]. Recently we found
in one patient that, after exercise, the intraventricular gra-
dient continues to increase if we mantained the patient in
orthostatic position.
The purpose of this study was to evaluate intraventricular
gradients by echocardiography during isotonic treadmill
exercise and immediate recovery period in upright posi-
tion, in patients with hypertrophic cardiomyopathy. This
study uses a different protocol from that described in a
previous study [22]: intraventricular gradients are meas-
ured during immediate recovery period in orthostatic
position instead of using supine position. This method
tries to mimic patients daily activities.
Methods
Patients
We studied seventeen patients diagnosed with hyper-
trophic cardiomyopathy based on the echocardiographic
finding of a nondilated hypertrophic left ventricle in the
absence of diseases known to cause ventricular hypertro-
phy [3]; eleven pts with obstructive HCM due to LVOT
gradient > 30 mmHg under resting conditions and six pts
with non-obstructive HCM; nine males, mean age 53 ± 16
years.
The study was approved by the Ethics Committe at Garcia
de Orta Hospital. All patients gave written informed con-
sent.
Echocardiography
Using standard techniques to obtain M-mode, two-
dimensional, and Doppler measurements, each patient
had two echocardiographic evaluations performed at rest:
one in left lateral decubitus, with assessment of left ventri-
cle (LV) dimensions (in systole and diastole), maximal LV
wall thickness and intraventricular gradient (using contin-
uous wave Doppler to evaluate gradients derived from
Doppler velocity profiles typical of subaortic obstruc-Cardiovascular Ultrasound 2008, 6:19 http://www.cardiovascularultrasound.com/content/6/1/19
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tion); the other in orthostatic position, with assessment of
intraventricular gradients after one minute in this posi-
tion.
The pts then underwent a treadmill exercise test using the
modified Bruce protocol, during which intraventricular
gradients were measured. Data were collected at peak
exercise and in recovery period in orthostatic position
(Figure 1) and segmental contractility was assessed at rest
and at peak exercise.
The exams were entirely recorded on videotape and par-
tially on optical disc.
Statistical analysis
Data are expressed as means ± standard deviation. Stu-
dent's t-test was used for comparisons between continu-
ous variables (systolic blood pressure, heart rate, gradients
measured by continuous wave Doppler in the LV outflow
tract at the various stages of the exercise stress echocardi-
ography). A P-value < 0.05 was considered significant.
Results
Baseline clinical and echocardiographic characteristics of
the 17 pts with HCM are summarized in Table 1.
Left ventricular dimensions were: end-diastolic diameter
47 ± 4 mm, end-systolic diameter 29 ± 4 mm, interven-
tricular septum thickness 17 ± 4,1 mm, posterior wall
thicknes 9 ± 2,4 mm, fractional shortening 37 ± 5%.
Seven patients had trivial or mild mitral regurgitation and
two moderate mitral regurgitation during rest in LLD.
On auscultation, nine patients had systolic murmurs on
the left sternal border.
Fourteen patients were in NYHA class II heart failure, and
three were in NYHA class III.
Eleven pts were on treatment with beta-blockers, four pts
with calcium channel blockers and two pts were on treat-
ment with calcium channel blockers and beta-blockers.
Intraventricular gradient present in all the phases of the study in one patient Figure 1
Intraventricular gradient present in all the phases of the study in one patient.Cardiovascular Ultrasound 2008, 6:19 http://www.cardiovascularultrasound.com/content/6/1/19
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They were all in sinus rhythm and none had a history of
syncope or arrhythmias (atrial fibrillation, ventricular or
supraventricular tachycardia) documented in their medi-
cal records.
Table 2 shows the exercise data for the 17 pts with HCM.
Good quality Doppler flows were obtained in all cases.
The values given for flow velocities are the mean of three
consecutive flows.
Three pts without resting obstruction developed intraven-
tricular gradient during exercice (Additional File 1, 2 and
3)); one patient developed gradient only in the recovery period
in orthostatic position (Figure 2); two pts had neither resting
nor exercise induced obstruction.
The flows recorded on optical disc were measured again
by the same operator and by another of the authors, and
showed good intra- and inter-observer agreement with no
statistically significant differences between measure-
ments.
No segmental contractility abnormalities were detected
either at rest or at peak exercise.
Pts with murmurs on initial evaluation (nine pts)
increased their intensity in orthostatic position; two pts
without murmur on initial assessment developed it dur-
ing effort; at the end of the exercise test, all but two
patients had clearly audible systolic murmurs on the left
sternal border.
There were no complications. Two patients had isolated
supraventricular extrasystoles and two patients isolated
ventricular extrasystoles.
The exercise test was interrupted by fatigue in all patients.
The mean time of exercise test was 398 ± 142 seconds.
Study limitations
The main limitations of the study are: the small size of the
sample; all patients were being medicated with beta-
blockers or calcium channel blockers, which probably
influenced the results; and it was not possible to obtain
good quality recordings of changes in the severity of
mitral regurgitation during the exercise test.
Discussion and Conclusion
Outflow gradients under resting conditions have been
shown to be independent determinants of progressive
heart failure symptoms and cardiovascular mortality in
HCM pts [13-16].
Heart failure symptoms and magnitude of LVOT gradients
may importantly affect clinical decisions in pts with HCM
[14,15,23]. Severely symptomatic drug-refractory patients
with outflow obstruction, either at rest or only with phys-
iological provocation, are potential candidates for inva-
sive septal reduction interventions to normalize LV
pressures and to improve symptoms [1].
Table 1: Baseline characteristics of 17 pts with HCM
Clinical parameters
Patients, n 17
Males/Females, n (%) 9 (53%)/8(47%)
Age (years-mean ± SD) 53 ± 16
NYHA II, n (%) 14 (82%)
NYHA III, n (%) 3 (18%)
Therapy, n (%)
Beta-blocker 11 (65%)
Calcium antagonist 4 (23%)
Beta-blocker and calcium antagonist 2 (12%)
Echocardiographic parameters (LLD)
LVOT gradient > 30 mmHg at rest, n (%) 11 (65%)
Mitral regurgitation at rest, n (%) 9 (53%)
Left ventricular end diastolic diameter (mm) 47 ± 4
Left ventricular end systolic diameter (mm) 29 ± 4
Interventricular septum thickness (mm) 17 ± 4,1
Posterior wall thickness (mm) 9 ± 2,4
Fractional shortening (%) 37 ± 5
NYHA = New York Heart Association
LVOT = left ventricular outflow tract
Table 2: Exercise data in 17 pts with HCM
At rest During exercise
Exercise parameter LLD Orthostatic position Peak exercise Post exercise orthostatic
Peak LVOT gradient, mmHg * 49 ± 24 62 ± 29 83 ± 35 96 ± 35
(p < 0.001 versus in LLD) (p < 0.001 versus supine rest) (p < 0.001 versus peak exercise)
Heart rate, bpm * 66 ± 8,6 74 ± 7,1 123 ± 11
Systolic blood pressure, mmHg * 128 ± 20 149 ± 18
* Values expressed as mean ± standard deviation
LVOT = left ventricular outflow tractCardiovascular Ultrasound 2008, 6:19 http://www.cardiovascularultrasound.com/content/6/1/19
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Recent studies [19,20] depart from the traditional notion
that LV outflow obstruction occurs in a minority of HCM
patients, concluding that most HCM patients are predis-
posed to LV outflow tract obstruction because of SAM-sep-
tal contact, either at rest or with physiological exercise
testing.
Exercise is the only provocative manoeuvre that is truly
physiologically based and similar to conditions under
which HCM patients develop symptoms [20]. The authors
selected upright treadmill exercise as the most similar to
pts daily activities, being a feasible methodology to define
intraventricular gradients during exercise in HCM patients
[22].
In the present study intraventricular gradient increases in
orthostatic position, increases significantly during tread-
mill exercise, and continues increasing in the recovery
period in upright position. These results diverge from pre-
vious studies, where intraventricular gradients decreased
when measured in supine position after exercise [22]. Gra-
dients in pts with obstructive HCM may increase after
change of position from supine to upright. Orthostatism
reduces preload by reducing venous return, thus increas-
ing the LV outflow tract gradient. Dynamic isotonic exer-
cise such as walking on a treadmill can lead to increased
intraventricular gradients by increasing ventricular con-
tractility and cardiac output [22]. Measuring intraven-
tricular gradients using echocardiography in supine
position, a routine practice in evaluation of patients with
Intraventricular gradient present only in the rcovery in orthostatic position Figure 2
Intraventricular gradient present only in the rcovery in orthostatic position.Cardiovascular Ultrasound 2008, 6:19 http://www.cardiovascularultrasound.com/content/6/1/19
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HCM does not reflect pts daily activities or the pathophys-
iology of this condition: supine position increases preload
by increasing venous return, thus decreasing LVOT gradi-
ent and underestimating obstruction. By keeping pts in
upright position after exercise, preload decreases due to
sudden interruption of venous blood pumping by mus-
cles, decreasing venous return and causing intraventricu-
lar gradients to increase. This could explain symptoms of
syncope/presyncope just after exercise in pts with HMC.
The finding that intraventricular gradients increase signif-
icantly when measured during exercise has been reported
by other authors using echocardiographic assessment dur-
ing bicycle ergometry [19,24]. However, the present study
is one of the few [22,25] with assessment carried out dur-
ing treadmill exercise testing. Using treadmill exercise
stress echocardiography to assess intraventricular gradi-
ents, allowed us to find that gradients increase signifi-
cantly not only with exercise but also with orthostatic
position before and after exercise. Intraventricular gradi-
ents assessed immediately after exercise in upright posi-
tion are higher than those measured during exercise in pts
with HCM.
These results suggest that measurements taken in decubi-
tus should be viewed with some caution in assessing the
severity of disease, as well as their relevance to the devel-
opment of symptoms. Previous studies which evaluate
LVOT gradients in pts with non-obstructive HCM during
immediate recovery period in decubitus [20] may have
underestimated their gradients, making it possible that
the number of pts considered to have obstructive HMC
may be superior to that stated.
In view of the fact that intraventricular gradients were
induced in up to two-thirds of symptomatic patients with
non-obstructive HCM during exercise in a recent study by
Shah et al, and were also induced in 4 of 6 pts with non-
obstructive HCM in the present study, the authors believe
that the methodology described would also be useful in
these patients [26], enabling to detect and quantify any
obstruction developing during exercise and in recovery
period in upright position, in order to determine its rele-
vance to the patient's symptoms and prognosis.
In this study, patients were under medication with beta-
blockers or calcium channel blockers, which were not sus-
pended for safety reasons [27]. The methodology used
could also be used to assess the efficacy of different types
of therapy for this pathology.
Conventional exercise stress testing as used in this study,
or with analysis of expired gases, is a valuable and safe aid
[27,28] in evaluating and managing patients with this
condition.
As a result of this small study, treatment was modified by
the consulting physicians in 8 patients: associating beta-
blockers in two patients medicated with verapamil, and
increasing beta-blocker dosage in six patients.
The evaluation of the intraventricular gradient with exer-
cise and in recovery period in upright position, can help
us to better understand the pathophysiology, symptoms
and to optimize treatment of pts with HCM.
Authors' contributions
RM review literature and wrote the manuscript. CC per-
formed exercise echocardiography, made clinical assess-
ment of the patients, participate in drafting, and revised
the manuscrip for important intellectual content. NC
revised the manuscript for important intellectual content.
SA, LL, MJL, OS, PC, PF, IJ are responsible for clinical
assessment of the patients, participate in drafting, and
revised the manuscrip for important intellectual content.
MC gave final approval for the manuscript. All authors
read and approved the final manuscript.
Additional material
References
1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ,
Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle
ED:  American College of Cardiology/European Society of
Cardiology Clinical Expert Consensus Document on Hyper-
trophic Cardiomyopathy. A report of the American College
of Cardiology Foundation Task Force on Clinical Expert
Consensus Documents and the European Society of Cardiol-
Additional file 1
Paraesternal view in one patient with non-obstructive hypertrophic cardi-
omyopathy. Two-dimensional paraesternal view, before exercise, showing 
normal morphology and funtion of left ventricle and mitral valve.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-6-19-S1.mpg]
Additional file 2
Apical 4 chamber view in one patient with non-obstructive hypertrophic 
cardiomyopathy. Apical 4 chamber view, before exercise showing normal 
flow evaluated with Doppler, showing clearly, the absence of obstruction.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-6-19-S2.mpg]
Additional file 3
Apical 4 chamber view in one patient with non-obstructive hypertrophic 
cardiomyopathy near peak exercise. Apical 4 chamber view, near peak 
exercise, showing the appearence of obstruction with Doppler.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-6-19-S3.mpg]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Cardiovascular Ultrasound 2008, 6:19 http://www.cardiovascularultrasound.com/content/6/1/19
Page 7 of 7
(page number not for citation purposes)
ogy Committee for Practice Guidelines.  Eur Heart J 2003,
24(21):1965-1991.
2. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG: Idio-
pathic hypertrophyc subaortic stenosis: I. A description of
the disease based upon na analysis of 64 patients.  Circulation
1964, 30(suppl IV):3-217.
3. Maron BJ: Hypertrophic cardiomyopathy: a systematic
review.  JAMA 2002, 287:1308-1320.
4. Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management
of hypertrophic cardiomyopathy.  N Engl J Med 1997,
336:775-785.
5. Klues HG, Schiffers A, Maron BJ: Phenotypic spectrum and pat-
terns of left ventricular hypertrophy in hypertrophic cardio-
myopathy: morphologic observations and significance as
assessed by two-dimensional echocardiography in 600
patients.  J Am Coll Cardiol 1995, 26:1699-1708.
6. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE:
Prevalence of hypertrophic cardiomyopathy in a general
population of young adults: Echocardiographyc analysis of
4111 subjects in the CARDIA study.  Circulation 92(4):785-9.
1995; Aug 15
7. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H,
Williams WG: Hypertrophic cardiomyopathy. The impor-
tance of the site and the extent of hypertrophy. A review.
Prog Cardiovasc Dis 1985, 28(1):1-83.
8. Henry WL, Clark CE, Griffith JM, Epstein SE: Mechanism of left
ventricular outflow obstruction in patients with obstructive
asymmetric septal hypertrophy (idiopathic hypertrophic
subaortic stenosis).  Am J Cardiol 1975, 35(3):337-345.
9. Maron BJ, Gottdiener JS, Roberts WC, Henry WL, Savage DD,
Epstein SE: Left ventricular outflow tract obstruction due to
systolic anterior motion of the anterior mitral leaflet in
patients with concentric left ventricular hypertrophy.  Circula-
tion 1978, 57(3):527-533.
10. Maron BJ, Harding AM, Spirito P, Roberts WC, Waller BF: Systolic
anterior motion of the posterior mitral leaflet: a previously
unrecognized cause of dynamic subaortic obstruction in
patients with hypertrophic cardiomyopathy.  Circulation 1983,
68(2):282-293.
11. Shah PM, Gramiak R, Kramer DH: Ultrasound localization of left
ventricular outflow obstruction in hypertrophic obstructive
cardiomyopathy.  Circulation 1969, 40(1):3-11.
12. McKenna WJ, Perry ME, et al.: Hypertrophic Cardiomyopathy.
Chapter 28.  In Textbook of Cardiovascular Medicine Volume 745.
Edited by: Robert M Califf, Jeffrey M. Isner, Eric N. Prystowsky. Lip-
pincott – Raven; 1998:68. 
13. Elliott PM, Gimeno JR, Tome MT, Shah J, Ward D, Thaman R,
Mogensen J, McKenna WJ: Left ventricular outflow tract
obstruction and sudden death risk in patients with hyper-
trophic cardiomyopathy.  Eur Heart J 2006, 27(16):1933-1941.
14. Autore C, Bernabo P, Barilla CS, Bruzzi P, Spirito P: The prognostic
importance of left ventricular outflow obstruction in hyper-
trophic cardiomyopathy varies in relation to the severity of
symptoms.  J Am Coll Cardiol 2005, 45(7):1076-1080.
15. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cec-
chi F, Maron BJ: Effect of left ventricular outflow tract obstruc-
tion on clinical outcome in hypertrophic cardiomyopathy.  N
Engl J Med 2003, 348(4):295-303.
16. Kofflard MJ, Ten Cate FJ, Lee C van der, van Domburg RT: Hyper-
trophic cardiomyopathy in a large community-based popula-
tion. Clinical outcome and identificationof risk factors for
sudden cardiac death and clinical deterioration.  J Am Coll Car-
diol 41(6):987-93. 2003; Mar 19
17. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE: Hyper-
trophic Cardiomyopathy: Interelation of clinical manifesta-
tion, pathophysiology, and therapy.  N Engl J Med
316(13):780-9. 1987; Mar 26
18. Kizilbash AM, Heinle SK, Grayburn PA: Spontaneous variability of
left ventricular outflow tract gradient in hypertrophic
obstructive cardiomyopathy.  Circulation 1998, 97(5):461-466.
19. Shah JS, Tome Esteban MT, Thaman R, Sharma R, Mist B, Pantazis A,
Ward D, Kohli SK, Page SP, Demetrescu C, Sevdalis E, Keren A, Pel-
lerin D, McKenna WJ, Elliott PM: Prevalence of Exercise Induced
Left Ventricular Outflow Tract Obstruction in Symptomatic
Patients with Non-obstructive Hypertrophic Cardiomyopa-
thy.  Heart . 2007 Nov 21
20. Maron M, Olivotto I, Zenovich A, Link M, Pandian N, Kuvin J, Nistri
N, Cecchi F, Udelson J, Maron BJ: Hypertrophic Cardiomyopathy
Is Predominantly a Disease of Left Ventricular Outflow
Tract Obstruction.  Circulation 2006, 114:2232-2239.
21. Cotrim C, Carrageta M: Stress-exercise echocardiography.  Rev
Port Cardiol 2000, 19(3):345-50.
22. Cotrim C, Loureiro MJ, Simoes O, Miranda R, Cordeiro P, Ialá M,
Matias C, João I, Carrageta M: Evaluation of hypertrophic
obstructive cardiomyopathy by exercise stress echocardiog-
raphy.  New methodology. Rev Port Cardiol 2005, 24(11):1319-27.
23. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J
Jr: Effects of beta adrenergic blockade on the circulation with
particular reference to observations in patients with hyper-
trophic subaortic stenosis.  Circulation 1964, 29:84-98.
24. Schwammenthal E, Schwartzkopff B, Block M, Johns J, Lösse B, Eng-
berding R, Borggrefe M, Breithardt G: Döppler echocardiographic
assessment of the pressure gradient during bicycle ergom-
etry in hypertrophic cardiomyopathy.  Am J Cardiol
69(19):1623-8. 1992; Jun 15
25. Dimitrow P, Bober M, Michalowska J, Sorysz D, Dubiel J: Left ven-
tricular outflow tract gradient provoked by upright position
or exercise in hypertrophic cardiomyopathy without
obstruction at rest.  Letter Heart . 2008 Feb 15
26. Decoulx E, Goullard L, Millaire A, Lecroart JL, de Groote P, Houdas
Y, Ducloux G: Left intraventricular gradients measured by
Döppler echocardiography at rest, during exercise and dur-
ing isoproterenol test in hypertrophic cardiomyopathy.  Arch
Mal Couer Vaiss 86(2):162-8. 1992 Jul 15
27. Drinko JK, Nash PJ, Lever HM, Asher CR: Safety of stress testing
in patients with hypertrophic cardiomyopathy.  Am J Cardiol
2004, 93:1443-1444.
28. Sharma S, Elliot P, Whyte G, Jones S, Mahon N, Whipp B, McKenna
WJ: Utility of cardiopulmonary exercise in the assessment of
clinical determinants of functional capacity in hypertrophic
cardiomyopathy.  Am J Cardiol 86(2):162-8. 2000 Jul 15